Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated Turnkey Solutions, Biomedical, and Investment Holding. Its Integrated Turnkey Solutions segment is engaged in the provision of integrated turnkey solutions for the related development of cleanrooms and the provision of related maintenance services. Its Biomedical segment is engaged in the provision of administrative health care services, operating medical laboratories, and developing regenerative wellness products. The Company provides laboratory services, including storage and handling of stem cell samples. Its services include stem cells, mesenchymal stem cells (MSC), natural killer (NK) cells, exosomes, and MSC exosomes. Its subsidiaries include Supergenics Solution Sdn. Bhd., Supergenics Life Science Sdn. Bhd., Supergenics Therapeutic Sdn. Bhd., Supergenics Bio Agro Sdn. Bhd., Supergenics Stembank Sdn. Bhd., and Supergenics Global Sdn. Bhd.
KUALA LUMPUR: The pipeline of initial public offerings (IPOs) is expected to remain healthy, as a total of 19 listings are expected by Bursa Malaysia Bhd this year, almost half of its target of 40 IPOs this year.
Bursa chief executive officer ...
The stock was last traded at 28 sen, 40% higher compared with its issue price of 20 sen. This is the first listing for Bursa Malaysia in 2020.
KUALA LUMPUR: Shares in Supergenics Bhd surged on its first day of trading on Bursa Malaysia’...
KUALA LUMPUR: Supergenics Bhd made a strong LEAP Market debut yesterday — the first listing of the year on Bursa Malaysia.
The stock, which opened at 22.5 sen, up 12.5% over its initial public offering (IPO) price of 20 sen a share, climbed further ...
Dirty dealings. Corporate battles. Consumer woes. Here are five things you need to know today.
1. MAHB group CEO Raja Azmi Raja Nazuddin quits, handing the reins over to its COO Datuk Mohd Shukrie Mohd Salleh.
2. The MACC prepares to announce ...
PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PRIVATE PLACEMENT")